Accuracy of lateral flow antigen tests for COVID-19, Royal College of Pathologists
The Royal College of Pathologists recognises the potential role of Lateral Flow Antigen Tests for COVID-19 (LFTAg) when used in a controlled and targeted way as part of an overall testing strategy. However, the public is reminded that the currently-used versions of these tests are not of sufficient sensitivity or accuracy to rule out the possibility that a negative result may not be correct. Whilst a negative LFTAg result reduces the chance that the person tested is infected, it does not eliminate it; therefore, that person could still potentially infect others. Individuals with negative LFTAg results should still observe social distancing and respiratory hygiene precautions (such as face masks covering the nose and mouth) whilst around others. Positive results by LFTAg should be confirmed by testing in a laboratory (using reverse transcription-polymerase chain reaction testing (RT-PCR)) as a matter of urgency. In the meantime, individuals with a positive LFTAg result should self-isolate pending the confirmatory test result.
Dysfunctional breathing, hypocapnia, and myalgic encephalomyelitis/chronic fatigue syndrome were seen in symptomatic patients post-acute COVID-19 despite normal chest imaging and pulmonary function.Medscape Medical News
Two days after the first case of the new Omicron Covid-19 variant was officially confirmed in Massachusetts, the head of the state's largest hospital system stressed the importance of vaccines and masks.
Prioritizing workforce well-being is a key driver of business success. The COVID-19 pandemic changed the world more than any event in recent history, significantly impacting the health and well-being of our workforce and economy. The inextricable link between individual health and productivity, business performance and economic prosperity is clear, and now is the time for employers to actively engage and support the mental and physical health of employees. In a recent survey by The Economist Intelligence…
Chris EdwardsThe main weapons against COVID-19 are the vaccines developed by Moderna and BioNTech after a decade of their research into mRNA technologies. That research was supported by more than $3 billion of private angel investment and venture capital.Democrats and Republicans both support medical research funding, and Republicans tout the Trump administration ’s Operation Warp Speed. But governments were not the key to mRNA development. Instead, we can thank the leaders and scientists at Moderna and BioNTech and the suppliers of private capital to them, as I discusshere andhere.TheWall Street Journal &r...
Fueled by new evidence that wildfire smoke can carry living microbes and is associated with a local increase in COVID-19 cases, scientists wonder if smoke might spread infectious diseases and worsen their effects
Jeffrey A. SingerPolitical polarization hinders progress against the COVID-19 pandemic.Political polarization may explain why, after former President Trump called the off ‐label use of the anti‐malarial drug hydroxychloroquine a “game‐changer” in the battle against COVID-19 (randomized controlled trials found that isnot the case), public health officials and the mainstream press appear uninterested in the off ‐label use of any other drugs as therapeutics against a COVID infection.For example, impressive data from randomized controlled trials show the off ‐label use of the off‐...
As scientists hunt for alternatives for people who can't access vaccines for COVID-19, they are searching underwater in unexpected places to study the therapeutic potential of edible marine algae.WebMD Health News
In updated guidance, IDSA suggests that healthcare personnel caring for patients with suspected or known COVID-19 use eye protection as part of appropriate personal protective equipment.Reuters Health Information
The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of vaccines against COVID-19.Reuters Health Information
A cruise ship that carried at least 17 passengers and crew members with breakthrough COVID-19 infections when it docked in New Orleans has set sail again with new passengers